Company Search:
Advanced Search
Sponsored Links
Oxford BioMedica plc Company Snapshot
Oxford BioMedica plc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oxford BioMedica plc with three other companies in this sector in the United Kingdom: GW Pharmaceuticals PLC (2018 sales of £20.00 million [US$26.29 million] of which 100% was Novel Therapeutics), Ergomed PLC (£54.11 million [US$71.11 million] of which 51% was Drug Safety and medical information serv), and Circassia Pharmaceuticals PLC (£48.30 million [US$63.47 million] of which 57% was operating-NIOX).

Sales Analysis. During the year ended December of 2018, sales at Oxford BioMedica plc were £66.78 million (US$87.75 million). This is an increase of 77.6% versus 2017, when the company's sales were £37.59 million. This was the fifth consecutive year of sales increases at Oxford BioMedica plc (and since 2013, sales have increased a total of 1,142%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oxford BioMedica plc
  Stock Performance Chart for Oxford BioMedica plc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 628.00p
(Figures in Pounds Sterling)
1 Week 0.8%   13 Weeks 11.7%  
4 Weeks 1.3%   52 Weeks -13.0%  
Oxford BioMedica plc Key Data:
  Ticker: OXB Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 66,778,000
(Year Ending Jan 2019).
Employees: 377
  Currency: Pounds Sterling Market Cap: 482,102,858
  Fiscal Yr Ends: December Shares Outstanding: 76,767,971
  Share Type: Ordinary Closely Held Shares: 16,872,045
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.